These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8873429)

  • 1. Anti-D testing in intravenous immunoglobulins: shouldn't it be considered.
    Pisani G; Wirz M; Gentili G
    Vox Sang; 1996; 71(2):132. PubMed ID: 8873429
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
    Crow AR; Lazarus AH
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D treatment for chronic immune thrombocytopenic purpura: clinical and laboratory aspects.
    Sagripanti A; Ferretti A; Giannessi D; Carpi A; Bernini W; Ambrogi F; De Caterina R
    Biomed Pharmacother; 1998; 52(7-8):293-7. PubMed ID: 9809171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment with SCIG of a Child with Refractory Chronic ITP.
    Karastaneva A; Klobassa DS; Minkov M; Benesch M; Seidel MG
    J Clin Immunol; 2019 Jan; 39(1):19-22. PubMed ID: 30631990
    [No Abstract]   [Full Text] [Related]  

  • 5. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.
    Mitterer M; Pescosta N; Vogetseder W; Mair M; Coser P
    Ann Hematol; 1993 Sep; 67(3):151-2. PubMed ID: 8373906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenous immunoglobulins and autoimmune thrombopenic purpura].
    Godeau B; Bierling P
    Rev Med Interne; 1999; 20 Suppl 4():440s-443s. PubMed ID: 10522320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal failure and intravenous immunoglobulin.
    Phillips AO
    Clin Nephrol; 1992 Apr; 37(4):217. PubMed ID: 1582064
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.
    Bierling P; Godeau B
    Hum Immunol; 2005 Apr; 66(4):387-94. PubMed ID: 15866702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.
    Levendoglu-Tugal O; Jayabose S
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):460-3. PubMed ID: 11878583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of childhood immune thrombocytopenic purpura.
    Lilleyman JS
    Lancet; 1994 Oct; 344(8930):1155. PubMed ID: 7934509
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
    Ruggeri M; Castaman G; De Nardi G; Rodeghiero F
    Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute idiopathic thrombocytopenic purpura--management in childhood.
    Bolton-Maggs PH
    Blood; 1997 Feb; 89(4):1465; author reply 1466. PubMed ID: 9028974
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid inflammation induced by intravenous immunoglobulins.
    Kressebuch H; Schaad UB; Hirt A; Bianchetti MG
    Pediatr Infect Dis J; 1992 Oct; 11(10):894-5. PubMed ID: 1408496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.